OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "Montana":

"… uller and Alexandra Duszak contributed to this report. …"

"… ate Sen. Jason Priest, a board member and former executive director of the Montana Growth Network, which produced radio advertisements and mailings during th …"

"… ufacturers of America (PhRMA) gave $500,000 to a nonprofit group called “Montana Growth,” as the Center for Public Integrity reported this week.Records a …"

"… ted this week.Records appeared to indicate the funding went to the only “Montana Growth” that reported any spending to Montana’s Commissioner of Politi …"

Federal regulators have failed to act on toxic chemical, report says

By Chris Hamby

Regulators have done little to protect the public from BPA, critics say

Report faults Medicare controls on widely abused drugs

By Joe Eaton

Beneficiaries easily went to multiple doctors for hydrocodone and oxycodone

Excerpts from this story referencing "Medicaid":

"… l practitioners in the same year.The GAO said the Centers for Medicare and Medicaid Services (CMS) has systems in place to identify inappropriate drug use by …"

"… l abuses.”  Witnesses from the GAO and the Centers for Medicare and Medicaid Services are expected to testify on the issue at Senate subcommittee heari …"

Inspectors struggle to keep up with flood of imports

By Brad Racino

Food imports approved for use in the U.S. in an unexpected way

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

FDA's flimsy recall power for food imports puts public at risk, watchdog says

By Aaron Mehta and Ben Wieder

FDA needs more power to police recalls of imported foods

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

Excerpts from this story referencing "Chile":

"… in fish farms abroad. In 2009, emamectin benzoate was found in salmon from Chile that was already accepted for import in the U.S. There is additional conce …"

During Mitch Daniels’ decade at Eli Lilly, the drug giant paid billions in fines and settled thousands of lawsuits

By Joanne Kenen and Rochelle Sharpe

Eli Lilly paid billions in fines, settled thousands of lawsuits while Daniels was an executive at the drug giant

Excerpts from this story referencing "Health":

"… s the work of person A, B, or C,” said Dr. Sidney Wolfe, director of the Health Research Group at Public Citizen. “It’s industry-wide corporate cultur …"

"… laims in some of its direct-to-consumer advertising about the drug in Health and Prevention magazines.Once a drug is approved by the FDA for a certain …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

FDA criticized for accepting free help from company that later won generic OK

By Laurel Adams

The Food and Drug Administration last month issued guidelines for agency staff to follow when drugmakers offer free help during emergencies

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

Excerpts from this story referencing "Research":

"… drugmaker submits an application to FDA’s Center for Drug Evaluation and Research. If it gets the agency’s green light, then the human clinical trials beg …"

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Excerpts from this story referencing "pharmaceutical":

"… ttle-noticed tentative agreement setting conditions under which a troubled pharmaceutical company and its subsidiary could resume the production and distribution of …"

"… Center story in December.The heart drug Digitek, which is produced by the pharmaceutical firm Actavis Inc., was recalled on April 25 by the firm’s subsidiary, Ac …"

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "laboratory and packaging services":

"… at closure also effectively shut two other Actavis facilities that provide laboratory and packaging services. In October, two members of the House of Representatives launched an inqui …"

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

Excerpts from this story referencing "Food and Drug Administration":

"… applications with the FDA has jumped four-fold since 1992, yet in 2007 the Food and Drug Administration (FDA) inspected only about one-tenth of the foreign establishments on its …"

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

Excerpts from this story referencing "David Graham":

"… of thousands of heart attacks. After the tragic failure, FDA whistleblower David Graham testified before a Senate committee that “the FDA, as currently configur …"

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

Excerpts from this story referencing "health products":

"… pharmaceutical industry — along with makers of medical devices and other health products — spent a record $189 million-plus on federal lobbying. Though the indus …"

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Excerpts from this story referencing "GlaxoSmithKline":

"… ded Roche Holding AG ($9 million), Sanofi-Aventis($8.4 million), GlaxoSmithKline ($8.2 million), Johnson & Johnson Inc. ($7.7 million) and the tra …"

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "health products":

"… ngs Foundation. …"

"… howed that the manufacturers of pharmaceuticals, medical devices and other health products have spent at least $855 million on lobbying from 1998, through June last …"

"… ; According to the Center for Responsive Politics, the pharmaceutical/health products sector gave nearly $107 million in federal campaign contributions. More th …"

PEPFAR policy hinders treatment in generic terms

By M. Asif Ismail

Critics say FDA approval rule has meant greater use of high-cost drugs at expense of helping fewer patients

Excerpts from this story referencing "Bush administration":

"… ic drugs has its roots in big pharmaceutical companies' influence with the Bush administration."Every step of the way, roadblocks were put to [ensure that generics were …"

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Excerpts from this story referencing "San Francisco":

"… nths of 2003 PhRMA spent $50,000 hosting 21 trips, including excursions to San Francisco, San Diego and Naples, Fla."America clearly has the best health care in th …"

Deep pockets contribute to success

By M. Asif Ismail

Industry spends millions on state campaign donations, Calif. fight

Excerpts from this story referencing "Virginia":

"… ns Gov. Rick Perry of Texas and Mark Earley, the party's 2001 candidate in Virginia.Pharmaceutical companies also spent significant amounts themselves on camp …"

States see importation as solution to high drug costs

By Victoria Kreha

Several seek, have plans despite federal and industry opposition

Excerpts from this story referencing "Virginia":

"… ross the border." Several other states, including Pennsylvania, Minnesota, Virginia and Tennessee, also have introduced bills proposing that they join the pro …"

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Excerpts from this story referencing "Health":

"… oups.At the behest of Congress, the Inspector General of the Department of Health and Human Services has investigated ties between the industry and the agen …"

"… ng perspective," said Dr. Peter Lurie, deputy director of Public Citizen's Health Research Group, which monitors the FDA and the Health industry. "They most …"

"… somebody else pays."In 2004, Congress examined the National Institutes of Health ethics programs after news reports documented that NIH and FDA employees e …"

"… ged in outside consulting work. The Inspector General of the Department of Health and Human Services — of which the FDA is a part — reviewed similar con …"

Drug lobby second to none

By M. Asif Ismail

How the pharmaceutical industry gets its way in Washington

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Excerpts from this story referencing "Abbott":

"… nization that receives support from the same companies, as well as Pfizer, Abbott, Sanofi-Aventis and Eli Lilly, and spent $1.5 million lobbying t …"

Checkbook politics

By Victoria Kreha

Over the last seven years, the pharmaceutical industry has given $150 million in campaign contributions

Excerpts from this story referencing "Center for Responsive Politics":

"… Public Integrity analysis of campaign finance records provided by the Center for Responsive Politics and the Institute on Money in State Politics. Sixty-five percent …"

"… deral campaign contributions, the Center used research by the non-partisan Center for Responsive Politics, based in Washington, D.C. The analysis on state political donations was b …"